In silico design of small molecules

Methods in Molecular Biology

Volumn 800, Issue , 2012, Pages 25-31

  Bernardo, Paul H ^a   Tong, Joo Chuan ^b  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bioinformatics; Computational biology; Computer aided drug design; Virtual chemical library; Virtual combinatorial library

Indexed keywords

BIOLOGY; CHEMISTRY; COMBINATORIAL CHEMISTRY; COMPUTER INTERFACE; DRUG DESIGN; INFORMATION PROCESSING; METHODOLOGY; MOLECULAR LIBRARY; REVIEW; SYNTHESIS;

AUTOMATIC DATA PROCESSING; COMBINATORIAL CHEMISTRY TECHNIQUES; COMPUTATIONAL BIOLOGY; DRUG DESIGN; SMALL MOLECULE LIBRARIES; USER-COMPUTER INTERFACE;

EID: 80555156091     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-349-3_3     Document Type: Review

References (27)

1. Klebe G (2006) Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today 11:580-594
2. Olah M, Mracec M, Ostopovici L et al (2004) WOMBAT: world of molecular bioactivity. In: Oprea TI (ed) Chemoinformatics in drug discovery, Wiley-VCH, New York
3. Goto S, Okuno Y, Hattori M et al (2002) LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res 30:402-404 (Pubitemid 34679597)
4. Irwin JJ, Shoichet BK (2004) ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177-182 (Pubitemid 40736970)
5. Wishart DS, Knox C, Guo AC et al (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668-672
6. Chen J, Swamidass SJ, Dou Y et al (2005) ChemDB: a public database of small molecules and related chemoinformatics resources. Bioinformatics 21:4133-4139 (Pubitemid 41672103)
7. Jónsdóttir SO, Jørgensen FS, Brunak S (2005) Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates. Bioinformatics 21:2145-2160 (Pubitemid 40740185)
8. Agrafiotis DK, Lobanov VS, Salemme FR (2002) Combinatorial informatics in the post-genomics era. Nat Rev Drug Discov 1:337-346 (Pubitemid 37361463)
9. Leland BA, Christie BD, Nourse JG et al (1997) Managing the combinatorial expansion. J Chem Inf Comput Sci 37:62-70
10. Leach AR, Bradshaw J, Green DVS et al (1999) Implementation of a system for reagent selection and library enumeration, profiling and design. J Chem Inf Comput Sci 39:1161-1172 (Pubitemid 129579852)
11. Lobanov VS, Agrafiotis DK (2002) Scalable methods for the construction and analysis of virtual combinatorial libraries. Combin Chem High-Throughput Screen 5:167-178 (Pubitemid 34475168)
12. Livingston DJ (2000) The characterization of molecular structures using molecular properties. A survey. J Chem Inf Comput Sci 40:195-209
13. Brown RD, Hassan M, Waldman M (2000) Combinatorial library design for diversity, cost efficiency, and drug-like character. J Mol Graph Model 18:427-437
14. O'Donovan C, Apweiler R, Bairoch A (2001) The human proteomics initiative (HPI). Trends Biotechnol 19:178-181 (Pubitemid 32280861)
15. Bohacek RS, McMartin C, Guida WC (1996) The art and practice of structure-based drug design: a molecular modelling perspective. Med Res Rev 16:3-50 (Pubitemid 26037075)
16. Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol 44:235-249 (Pubitemid 32239479)
17. Hou T, Wang J, Zhang W et al (2006) Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr Med Chem 13:2653-2667 (Pubitemid 44364143)
18. Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55-68
19. Oprea T (2000) Property distribution of drugrelated chemical databases. J Comput Aided Mol Des 14:251-264 (Pubitemid 30175944)
20. Wenlock MC, Austin RP, Barton P et al (2003) A comparison of physicochemical property profiles of development and marketed oral drugs. J Med Chem 46:1250-1256 (Pubitemid 36428230)
21. Congreve M, Carr R, Murray C et al (2003) A "rule of three" for fragment-based lead discovery? Drug Discov Today 8:876-877 (Pubitemid 37194496)
22. Song CM, Tong JC (2009) Recent advances in computer-aided drug design. Brief Bioinform 10:579-591
23. Gasteiger J, Marsili M (1978) A new model for calculating atomic charges in molecules. Tetrahedron Lett 19:3181-3184
24. Cornell WD, Cieplak P et al (1995). A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J. Am Chem Soc 117: 5179-5197
25. Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comp Chem 17:490-519 (Pubitemid 126567067)
26. Jakalian A, Jack DB, Bayly CI (2002) Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 23:1623-1641 (Pubitemid 35330860)
27. Baell JB, Holloway GA (2010) New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays. J Med Chem 53:2719-2740